Publications by authors named "M P Teissier"

Background: Gestational diabetes mellitus (GDM) incurs risks for both mother and baby and requires close medical attention throughout pregnancy. This retrospective study examined the impact of myDiabby® software on GDM care and complications.

Material And Methods: The study population was divided between a pre-MyDiabby® group, with traditional monitoring before September 2017, and a myDiabby® group, using the myDiabby® app after September 2017.

View Article and Find Full Text PDF
Article Synopsis
  • Duodenal neuroendocrine tumours (D-NETs) are rare but increasingly diagnosed, with treatment options including endoscopic or surgical resection based on tumor characteristics.
  • A multicenter study in France analyzed the management and outcomes of 153 patients with non-metastatic D-NETs from 2000 to 2019, finding no significant differences in recurrence-free survival between those treated with endoscopic resection (ER) and surgical resection (SR).
  • The study concluded that both treatment types led to similar patient outcomes, with surgery providing higher rates of complete resection but also more surgical complications.
View Article and Find Full Text PDF

The number of elderly people with type 2 diabetes (T2D) is increasing worldwide. Community pharmacies, thanks to their proximity, provide more easy access to therapeutic education for rural patients. Populations living in isolated areas require specific educational resources related to their condition.

View Article and Find Full Text PDF

Context: Germline CDKN1B variants predispose patients to multiple endocrine neoplasia type 4 (MEN4), a rare MEN1-like syndrome, with <100 reported cases since its discovery in 2006. Although CDKN1B mutations are frequently suggested to explain cases of genetically negative MEN1, the prevalence and phenotype of MEN4 patients is poorly known, and genetic counseling is unclear.

Objective: To evaluate the prevalence of MEN4 in MEN1-suspected patients and characterize the phenotype of MEN4 patients.

View Article and Find Full Text PDF
Article Synopsis
  • * Results showed significant improvements in key measures: time in range (TIR) increased by 9.1%, HbA1c decreased by 0.5%, and notable reductions in time spent below and above target levels.
  • * The majority of patients (92.7%) continued using the system, and more achieved glycemic goals after one year, although there were some reported cases of severe hypoglycemia and ketoacidosis.
View Article and Find Full Text PDF